North America
The North America Oncology Biosimilars Market is expanding rapidly, largely driven by the increasing prevalence of cancer and the high cost of biologic treatments. The United States dominates this market with extensive biosimilar approvals by the FDA, a robust healthcare infrastructure, and initiatives to reduce healthcare costs. Canada is also experiencing growth due to...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian